Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
Exclusive: Another PBOC Official Is Under Probe, Possibly Tied to Third-Party Payment
IPhone Manufacturer Gets Into Electric Cars Via Fiat Venture
Investors Cash Out of Online Lender Qudian’s After Guidance Withdrawal
LATEST
Property Giant Evergrande Pays 12% in New Bond Financing
More Virtual Banks to Switch On in Hong Kong
Geely’s Volvo Links Up With China Unicom on 5G for Self-Driving Cars
Investors Cash Out of Online Lender Qudian’s After Guidance Withdrawal
China-U.S. Trade Deal Hardly Addresses Issue of Technology Transfer
Tesla Eyes Design and Research Center for ‘Chinese-Style’ Cars
IPhone Manufacturer Gets Into Electric Cars Via Fiat Venture
Exclusive: Another PBOC Official Is Under Probe, Possibly Tied to Third-Party Payment
‘Chunyun’ Helps Travel-Related Apps Grow Their Active Users in December, Survey Shows
Rising Air Pollution Across China Clouds Clear Skies in Beijing and Shanghai: Report
Huawei Asks U.K. Developers to Help Build App Ecosystem Amid Android Ban
WeChat Tests Pay-to-Read Feature for Public Blogging Accounts
Listed Internet Firms Rally in Fourth Quarter
Beijing Media Company Enlight Announce One Billion Yuan Investment in Animation
JD.com Doubles Down on Smaller-Cities Expansion to Bolster 2020 Growth
Big China Tech Feasts, as Startups Go Hungry
Beyond Meat Shares Rise on Executive’s China Comments
Government Push on Electronic Toll Collection System Fuels Supplier Growth
Yum China Mulls Second Listing in Hong Kong, News Reports Say
PBOC Selects Six Pilot Projects Under Fintech Development Plan
Chinese Genomics Giant BGI Wages Patent War Against Illumina

By Wang Luyao and Han Wei / May 30, 2019 03:24 AM / Business & Tech

Photo: IC Photo

Photo: IC Photo

A unit of China’s leading genetic testing company BGI Group filed a patent infringement case against U.S. genomics giant Illumina Inc. in an escalation of patent disputes surrounding key DNA sequencing technologies.

BGI’s gene sequencing manufacturing subsidiary MGI Tech Co. said Wednesday that its U.S.-based unit Complete Genomics filed the case in Delaware demanding that Illumina immediately stop selling several sequencing products and related sequencing chemistry reagents that allegedly violate BGI patents.

The latest development reflected a heated patent battle between the two genomics companies. Illumina filed two lawsuits in March and May in Europe accusing BGI of patent infringement.

In a statement to Caixin last week, BGI said it “will take corresponding legal actions” to deal with the legal disputes with Illumina and “will not rule out the use of legal weapons such as counterclaims to protect its legal rights.”

In a letter to Caixin, Illumina called the BGI's claims “meritless” and said it "fully expects to succeed in the litigation".

Share this article
Open WeChat and scan the QR code